Gary Pace

Gary W Pace was appointed Non-Executive Director in April 2016. Dr Pace has more has more than 40 years of experience in the development and commercialization of advanced life sciences and related technologies, spanning biotechnology, pharmaceuticals, medical devices, and food industries. Dr Pace has contributed to the development of the biotechnology industry through honorary university appointments and industry and government committees.

Dr. Pace is currently a Director of Pacira Pharmaceuticals Inc (NASDAQ: PCRX);and Antisense Therapeutics (ASX: ANP) as well as several private companies.

Dr. Pace holds a B.Sc. (Hons I) from the University of New South Wales and a Ph.D. from the Massachusetts Institute of Technology.